Mirvetuximab Biosimilar - Research Grade
Product Specifications
Background
Uses the same sequence as the therapeutic antibody Mirvetuximab
Specifications
Detects human FOLR1
Species Reactivity
Human
Target
FOLR1
Applications
Functional Assays
Purification Method
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Concentration
5mg/mL
Endotoxin
<1EU/mg Determined by LAL gel clotting assay
Purity
≥95% monomer by analytical SEC, >95% by SDS Page
Buffer
ICH3002
Shipping Conditions
Blue ice
Storage Conditions
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Applications Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Explore Other Products
Browse additional items from our catalog
FZD1, ID (Frizzled-1, Fz-1, hFz1, FzE1) (MaxLight 490) discontinued
POU5F2 (POU Domain Class 5, Transcription Factor 2, DKFZp686P02123, FLJ25680, SPRM-1) (FITC)
POU5F2 (POU Domain Class 5, Transcription Factor 2, DKFZp686P02123, FLJ25680, SPRM-1) (FITC)
Recombinant Human CXCL2 / C-X-C Motif Chemokine Ligand 2, Animal Free & Carrier Free
